The life sciences sales and marketing function lacks a differentiated and coherent strategy to actively engage with its variety of stakeholders (physicians, patients, payers, pharmacists, nurse practitioners, and NGOs / advocacy groups). These firms struggle to find solutions that address the issues of pay-for-performance, prevention & wellness, and counterfeit drugs. Startups leverage analytics, IoT, cloud computing, and mobility to address these challenges. In this report, we analyzed over 150 startups and shortlisted five leading ones based on business disruption, technology disruption, and market buzz. They are Aktana, Sproxil, TraceLink, Verix, and Zephyr Health.
In this report, starting with a long list of over 150 candidates, we analyze 5 hot life sciences startups focused on disrupting sales and marketing. We focus on:
- Hot life sciences startups: key players driving disruption
- Funding scenario
- Key investors
- Leading investment areas
- Life sciences startups shortlist
- Startups leaderboard
- Implications for enterprises
- Implications for service providers
- Sales and marketing: industry trends and startups
- Current status
- Innovation trends
- Changing the status quo
- Leading startups and profiles
- Business overview
- Leadership details
- Funding trail
- Disruption across technology & business
- Market buzz
The full report –Hot Drug Discovery / Product Development Startups:
Friends, Foes, and Frenemies in the Innovation Ecosystem – encompasses 20 hot life sciences startups across three investment areas – drug discovery / product development, clinical & pre-clinical trials, and sales & marketing.
Membership(s)
Healthcare & Life Sciences IT Outsourcing
